Cornerstone Pharmaceuticals, Inc

Cranbury, New Jersey 08512

We've found

1 trials

at this facility

Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome

Status: Upcoming, Phase II
Updated: 2/2/2015

from

Cranbury, NJ

Use our guide to learn which trials are right for you!